Marksans Pharma Ltd.

NSE: MARKSANS | BSE: 524404 | ISIN: INE750C01026 | Industry: Pharmaceuticals
| Falling Comet
161.5000 1.30 (0.81%)
NSE Mar 24, 2026 11:37 AM
Volume: 513.3K
 

161.50
0.81%
Dynamic Levels
Marksans R&D; capabilities include dossier development, chemical synthesis, process optimization, formulation development, analytical development and conducting stability studies. The company has a team of over 50 experienced scientists specializing in formulation development and analytical development. The conpany has possessed end-to-end capabilities from Lab scale development to Pilot scale up and from commercializing the product for large...
Number of FII/FPI investors decreased from 146 to 137 in Dec 2025 qtr
More from Marksans Pharma Ltd.
Recommended